• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清维生素 D3 作为冒烟型多发性硬化症神经元损伤的潜在生物标志物。

Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis.

机构信息

Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3-go Maja 13-15, 41-800 Zabrze, Poland.

Klaipeda University Hospital, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

出版信息

Int J Mol Sci. 2024 Sep 29;25(19):10502. doi: 10.3390/ijms251910502.

DOI:10.3390/ijms251910502
PMID:39408830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11476431/
Abstract

Permanent inflammatory demyelinating and neurodegenerative processes lead to neurological disability in patients with multiple sclerosis (MS). The anti-inflammatory properties of vitamin D (VitD) are well established, but its role in neurodegeneration is still uncertain. The usefulness of the serum concentration of VitD as a potential biomarker in evaluating brain injury in terms of recently known smoldering MS was under consideration. Methods: We assessed the concentrations of the parameters of brain injury (NF-H, GPAF, S100B, UCHL1) in the cerebrospinal fluid (CSF) of relapsing-remitting (RRMS, = 123) and progressive MS (PMS, = 88) patients in the group with normal levels of VitD (VitDn) and in the VitD deficiency group (VitDd). The levels of NF-H and UCHL1 were higher in the group of VitDd compared to VitDn. The higher serum levels of VitD were correlated with lower concentrations of GFAP, NF-H and S100B in the CSF of the whole group of MS patients and in women with MS as opposed to the levels of UCHL1. In men, there were noted negative correlations between the levels of serum VitD and GFAP and NF-H in CSF but not between VitD and S100B and UCHL1. The negative correlations were observed between VitD and the selected parameters of brain injury in MS patients, in women as well as in men. The concentrations of serum VitD together with selected parameters of brain injury in CSF seem to be promising biomarkers of neurodegeneration processes in smoldering MS.

摘要

持续性炎症性脱髓鞘和神经退行性过程导致多发性硬化症(MS)患者出现神经功能障碍。维生素 D(VitD)的抗炎特性已得到充分证实,但它在神经退行性变中的作用仍不确定。考虑到最近已知的潜伏性 MS,我们正在研究血清 VitD 浓度作为评估脑损伤的潜在生物标志物的有用性。方法:我们评估了复发缓解型 MS(RRMS,n=123)和进展型 MS(PMS,n=88)患者 VitD 正常组(VitDn)和 VitD 缺乏组(VitDd)脑脊液中脑损伤参数(NF-H、GPAF、S100B、UCHL1)的浓度。与 VitDn 相比,VitDd 组 NF-H 和 UCHL1 水平更高。在整个 MS 患者组和 MS 女性患者中,VitD 血清水平较高与 CSF 中 GFAP、NF-H 和 S100B 浓度降低相关,而与 UCHL1 水平无关。在男性中,血清 VitD 水平与 CSF 中 GFAP 和 NF-H 之间存在负相关,但 VitD 与 S100B 和 UCHL1 之间不存在负相关。VitD 与 MS 患者、女性和男性的选定脑损伤参数之间存在负相关。血清 VitD 浓度与 CSF 中选定的脑损伤参数似乎是潜伏性 MS 中神经退行性过程的有前途的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/ff821d44efae/ijms-25-10502-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/bb0afef0684a/ijms-25-10502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/7e9674d866a1/ijms-25-10502-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/2ef91f6838c6/ijms-25-10502-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/ff821d44efae/ijms-25-10502-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/bb0afef0684a/ijms-25-10502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/7e9674d866a1/ijms-25-10502-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/2ef91f6838c6/ijms-25-10502-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1deb/11476431/ff821d44efae/ijms-25-10502-g004.jpg

相似文献

1
Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis.血清维生素 D3 作为冒烟型多发性硬化症神经元损伤的潜在生物标志物。
Int J Mol Sci. 2024 Sep 29;25(19):10502. doi: 10.3390/ijms251910502.
2
Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.评估血清 NfL、GFAP、UCHL1 和 tTAU 作为神经炎症和多发性硬化症中 CSF 水平和诊断工具的估计值的效用。
Mult Scler Relat Disord. 2024 Jul;87:105644. doi: 10.1016/j.msard.2024.105644. Epub 2024 Apr 26.
3
Can Selected Parameters of Brain Injury Reflect Neuronal Damage in Smoldering Multiple Sclerosis?脑损伤的选定参数能否反映隐匿性多发性硬化中的神经元损伤?
Diagnostics (Basel). 2024 Sep 9;14(17):1993. doi: 10.3390/diagnostics14171993.
4
S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.S100B作为多发性硬化症的潜在生物标志物和治疗靶点。
Mol Neurobiol. 2016 Aug;53(6):3976-3991. doi: 10.1007/s12035-015-9336-6. Epub 2015 Jul 17.
5
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.多发性硬化症(MS)队列中的神经胶质和神经轴突生物标志物
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:113-121.
6
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury.将侵袭性多发性硬化的临床和 MRI 拟议标准与神经轴突和神经胶质损伤的血清和脑脊液标志物相匹配。
J Neurol. 2024 Jun;271(6):3512-3526. doi: 10.1007/s00415-024-12299-z. Epub 2024 Mar 27.
7
Serum GFAP as a biomarker for disease severity in multiple sclerosis.血清 GFAP 作为多发性硬化症疾病严重程度的生物标志物。
Sci Rep. 2018 Oct 4;8(1):14798. doi: 10.1038/s41598-018-33158-8.
8
Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.tau 磷酸化状态的生物标志物与多发性硬化症的临床病程相关。
Mult Scler Relat Disord. 2024 Oct;90:105801. doi: 10.1016/j.msard.2024.105801. Epub 2024 Aug 5.
9
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.孕激素治疗并未降低中重度创伤性脑损伤患者神经胶质和神经元细胞损伤生物标志物的血清水平:创伤性脑损伤孕激素、实验性临床治疗(ProTECT)III 试验的二次分析。
J Neurotrauma. 2021 Jul 15;38(14):1953-1960. doi: 10.1089/neu.2020.7072. Epub 2021 Jan 25.
10
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.多发性硬化症中不同神经胶质细胞反应的标志物:临床与病理相关性
Brain. 2002 Jul;125(Pt 7):1462-73. doi: 10.1093/brain/awf165.

引用本文的文献

1
Vitamin D and Neurodegenerative Diseases Such as Multiple Sclerosis (MS), Parkinson's Disease (PD), Alzheimer's Disease (AD), and Amyotrophic Lateral Sclerosis (ALS): A Review of Current Literature.维生素D与神经退行性疾病,如多发性硬化症(MS)、帕金森病(PD)、阿尔茨海默病(AD)和肌萎缩侧索硬化症(ALS):当前文献综述
Curr Nutr Rep. 2025 Jun 4;14(1):77. doi: 10.1007/s13668-025-00663-y.
2
Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review.同型半胱氨酸、不对称二甲基精氨酸及维生素相关通路改变在某些神经退行性疾病中的影响:一项叙述性综述
Int J Mol Sci. 2025 Apr 13;26(8):3672. doi: 10.3390/ijms26083672.
3

本文引用的文献

1
Vitamin D-An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis.维生素 D-在进展性多发性硬化症动物模型中的有效抗氧化剂。
Nutrients. 2023 Jul 26;15(15):3309. doi: 10.3390/nu15153309.
2
The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update.维生素 D 在多发性硬化症神经保护中的作用:最新研究进展。
Nutrients. 2023 Jun 30;15(13):2978. doi: 10.3390/nu15132978.
3
Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy.
Elucidating SARS-CoV-2 neurotropism: a comprehensive Mendelian randomization study on cerebrospinal fluid biomarkers and their relevance to COVID-19 neurological manifestations.
阐明严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的嗜神经性:一项关于脑脊液生物标志物及其与冠状病毒病2019(COVID-19)神经表现相关性的综合孟德尔随机化研究。
Virol J. 2025 Apr 28;22(1):123. doi: 10.1186/s12985-025-02754-2.
多发性硬化症中的脑容量损失与疾病活动无关,并且可能通过早期的疾病修正治疗来预防。
Neurol Neurochir Pol. 2023;57(3):282-288. doi: 10.5603/PJNNS.a2023.0031. Epub 2023 May 5.
4
Clinical and Imaging Outcomes after Vitamin D Supplementation in Patients with Multiple Sclerosis: A Systematic Review.维生素 D 补充治疗多发性硬化症患者的临床和影像学结局:系统评价。
Nutrients. 2023 Apr 18;15(8):1945. doi: 10.3390/nu15081945.
5
Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders.分子视角下维生素 D 缺乏对神经紊乱疾病的致病影响。
Biomed Pharmacother. 2023 Jun;162:114718. doi: 10.1016/j.biopha.2023.114718. Epub 2023 Apr 20.
6
UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing-remitting type of multiple sclerosis.UCHL1 除了瘦素和纤维连接蛋白外,也可能是复发性多发性硬化症的敏感标志物。
Sci Rep. 2023 Feb 28;13(1):3423. doi: 10.1038/s41598-023-30237-3.
7
Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury.UCHL1 在神经退行性疾病和脑损伤发病机制中的作用。
Ageing Res Rev. 2023 Apr;86:101856. doi: 10.1016/j.arr.2023.101856. Epub 2023 Jan 19.
8
Multiple sclerosis progression: time for a new mechanism-driven framework.多发性硬化症的进展:是时候建立一个新的基于机制的框架了。
Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18.
9
The effect of vitamin D supplementation on oxidative stress and inflammatory biomarkers in pregnant women: a systematic review and meta-analysis of clinical trials.维生素 D 补充对孕妇氧化应激和炎症生物标志物的影响:临床试验的系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2022 Nov 5;22(1):816. doi: 10.1186/s12884-022-05132-w.
10
Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.羟氯喹治疗原发性进行性多发性硬化症患者的血清神经丝轻链和胶质纤维酸性蛋白水平。
Eur J Neurol. 2023 Jan;30(1):187-194. doi: 10.1111/ene.15588. Epub 2022 Oct 25.